Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by fairweather1on Jun 24, 2014 6:37am

208 Views

Post# 22688324

revenue

I note that mgt often brags about existing revenue being there to help cover R&D, but if you look at the last few years, revenue has been steadily declining. Has mgt commented on that in any recent MDA or press releases?

I know there is a new laser coming out later this year. Is that supposed to claw back some market share?

Bullboard Posts

Opawica seeks drill permits for Bazooka Gold Targets in Abitibi